Therapeutic efficacy of Artemether/Lumefantrine (Coartem®) against plasmodium falciparum in Kersa, South West Ethiopia

Parasites and Vectors

Volumn 3, Issue 1, 2010, Pages

  Assefa, Ashenafi ^a   Kassa, Moges ^a   Tadese, Gemechu ^a   Mohamed, Hussen ^a   Animut, Abebe ^b   Mengesha, Tesfayae ^a  

^a ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; HEMOGLOBIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CHILD; CLEARANCE; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG TREATMENT FAILURE; ETHIOPIA; FATIGUE; FEMALE; FEVER; FOLLOW UP; GAMETOCYTE; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MOUTH ULCER; MUSCLE WEAKNESS; NONHUMAN; PLASMODIUM FALCIPARUM; SLEEP DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

PLASMODIUM FALCIPARUM;

EID: 76749163402     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-3-1     Document Type: Article

References (21)

1. Drug resistance in malaria. Malaria Epidemiology Branch Centers for Disease Control and Prevention. BB Peter, Chamblee, GA, United States of America 2001
2. Assessment and monitoring of antimalrial drug efficacy for the treatment of uncomplicated falciparum Malaria. WHO (World Health Organization), 2003 http://malaria.who.int/docs/ProtocolWHO.pdf
3. Malaria diagnosis and treatment a guideline for health workers in Ethiopia. FMOH (Federal Republic Ethiopia, Ministry of Health), 2004
4. Efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Ethiopia. D Jima G Tesfaye A Medhin A Kebede D Argaw O Babaniyi, East Afr Med J 2005 82 391 95 16261914
5. Changing patterns of clinical malaria since 1965 among a tea estate population located in the Kenyan highlands. GD Shanks K Biomndo SI Hay RW Snow, Trop Med Hyg 2000 94 253 55 10.1016/S0035-9203(00)90310-9
6. Malaria fact sheet No 94. WHO (World Health Organization), Geneva 1996
7. A Longitudinal Study of Type-Specific Antibody Responses to Plasmodium falciparum Merozoite Surface Protein-1 in an Area of Unstable Malaria in Sudan. DR Cavanagh IM Elhassan C Roper VJ Robinson H Giha AA Holder L Hviid TG Theander DE Arnot JS McBride, J Immunol 1998 161 1 347 359 9647243
8. No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. J Zwetyenga C Rogier A Tall D Fontenille G Snounou JF Trape O Mercereau-Puijalon, Am J Trop Med Hyg 1998 59 5 726 735 9840589
9. Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. F Ntoumi H Contamin C Rogier S Bonnefoy JF Trape O Mercereau-Puijalon, Am J Trop Med Hyg 1995 52 1 81 88 7856831
10. Efficacy and safety of CGP56697(artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria inTanzania children aged 1-5 years. C Hatz S Abdulla R Mull D Schellenberg I Gathmann P Kibatala HP Beck MRC Tanner, Trp med Int heal 1998 3 498 504 10.1046/j.1365-3156.1998.00250.x (Pubitemid 28283576)
11. No evidence of cardiotoxicity during antimalarial treatment with Artemether-lumefantrine. M Van Vugt F Ezzet F Nosten I Gathmann P Wilairatana S Looareesuwan NJ White, Am J Trop Med Hyg 1999 61 964 67 10674679
12. A clinical and pharmacokinetic trial of six doses of Artemether lumefantrine for multidrug-resistant plasmodium falciparum malaria in Thailand. G LefeVre S Looareesuwan S Treeprasertsuk S Krudsood U Silachamroon I Gathmann R Mull R Bakshi, Am J Trop med hyg 2001 64 247 56 11463111
13. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated plasmodium falciparum malaria In Uganda. C Fogg F Bajunirwe P Piola S Biraro F Checchi J Kiguli P Namiiro J Musabe A Kyomugisha J Guthmann, Am J Trop Med Hyg 2004 71 525 30 15569777
14. Artesunate combination for treatment of Malaria: Meta-analysis. Internatioanal Artemisinin study group, Lancet 2004 363 9 17 10.1016/S0140-6736(03)15162-8 14723987
15. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. P Piola C Fogg F Bajunirwe S Biraro F Grandesso E Ruzagira J Babigumira I Kigozi J Kiguli J Kyomuhendo L Ferradini W Taylor F Checchi JP Guthman, Lancet 2005 365 1467 73 10.1016/S0140-6736(05)66416-1 15850630
16. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. M Mulenga JP Van Geertruyden L Mwananyanda V Chalwe F Moerman R Chilengi CV Overmeir JC Dujardin U D'Alessandro, Mal J 2006 5 73 79 10.1186/1475-2875-5-73 (Pubitemid 44481293)
17. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-mefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects. G Lefèvre P Carpenter C Souppart H Schmidli M McClean D Stypinski, J Clin Pharmacol 2002 54 485 92
18. Assessment of public health implication of Malaria-Hookworm Co-infection in Asendabo, south west Ethiopia. F Demissie, MSc thesis Addis Ababa Univesity, Department of Biology 2007
19. A randomized controlled trial of artemether/benflumetol, a new Antimalarial and pyrimethamine/sulfadoxine in the treatment of Uncomplicated falciparum malaria in African children. LV Seidlein K Bojang P Jones S Jaffar M Pinder S Obaro T Doherty M Haywood G Snounou B Gemperli I Gathmann C Royce K Mcadam B Greenwood, Am J Trop Med Hyg 1998 58 638 44 9598454
20. International package leaflet. AG Novartis pharma, Basel, Switzerland 2005
21. Artesunate reduces but does not prevent post treatment transmission of Plasmodium falciparum to Anopheles gambiae. G Targett C Drakeley M Jawara L Seidlein R Coleman J Deen M Pinder T Doherty, J Inf Dis 2001 183 1254 59 10.1086/319689 (Pubitemid 32281565)